JGP Global Gestao de Recursos’s Sarepta Therapeutics SRPT Stock Holding History

JGP Global Gestao de Recursos’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,538	Closed	-$262K	–	63
2020 Q4	$262K	Sell	1,538 -106	-6%	-$15.7K	0.99%	38
2020 Q3	$231K	Sell	1,644 -99	-6%	-$15K	0.13%	54
2020 Q2	$279K	Sell	1,743 -732	-30%	-$99.6K	0.17%	47
2020 Q1	$319K	Hold	2,475	–	–	0.14%	45
2019 Q4	$319K	Buy	+2,475	New	+$250K	0.11%	52
2019 Q3	–	Sell	-2,399	Closed	-$365K	–	76
2019 Q2	$365K	Sell	2,399 -5,515	-70%	-$670K	0.14%	34
2019 Q1	$943K	Buy	7,914 +748	+10%	+$96.2K	0.35%	17
2018 Q4	$782K	Buy	+7,166	New	+$896K	0.95%	13

Other funds holding SRPT

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

JGP Global Gestao de Recursos's SRPT Position: Q1 2021 in Review

JGP Global Gestao de Recursos sold out of Sarepta Therapeutics (SRPT) in Q1 2021, closing a stake of 1,538 shares — an estimated $262K sold.

JGP Global Gestao de Recursos first reported a position in SRPT in Q4 2018 and held it in 8 quarters. The position peaked at $943K in Q1 2019. 366 funds tracked by Wall St. Rank hold SRPT as of Q1 2021.

JGP Global Gestao de Recursos reported no remaining Sarepta Therapeutics position as of Q1 2021 after selling out during the quarter.
JGP Global Gestao de Recursos sold 1,538 Sarepta Therapeutics shares in Q1 2021, an estimated $262K.
JGP Global Gestao de Recursos first reported a position in Sarepta Therapeutics in Q4 2018 and held it in 8 quarters.
JGP Global Gestao de Recursos's Sarepta Therapeutics position peaked at $943K in Q1 2019.
366 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2021.

Based on JGP Global Gestao de Recursos's 13F filing for Q1 2021, filed 11 May 2021.